ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Lipocine Inc

Lipocine Inc (LPCN)

6.59
-0.04
(-0.60%)
Closed May 29 4:00PM
6.97
0.38
(5.77%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
6.59
Bid
6.50
Ask
6.90
Volume
22,697
6.5001 Day's Range 6.97
2.3101 52 Week Range 7.15
Market Cap
Previous Close
6.63
Open
6.68
Last Trade
1
@
6.97
Last Trade Time
Financial Volume
$ 150,577
VWAP
6.6342
Average Volume (3m)
72,451
Shares Outstanding
5,315,830
Dividend Yield
-
PE Ratio
-2.27
Earnings Per Share (EPS)
-3.08
Revenue
-2.85M
Net Profit
-16.35M

About Lipocine Inc

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other produ... Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other products in the pipeline such as LPCN 1144 LPCN 1148 and LPCN 1107. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Lipocine Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LPCN. The last closing price for Lipocine was $6.63. Over the last year, Lipocine shares have traded in a share price range of $ 2.3101 to $ 7.15.

Lipocine currently has 5,315,830 shares outstanding. The market capitalization of Lipocine is $37.05 million. Lipocine has a price to earnings ratio (PE ratio) of -2.27.

LPCN Latest News

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024 PR Newswire SALT LAKE CITY, May 9, 2024 SALT LAKE CITY, May 9, 2024 /PRNewswire/ --ย Lipocine Inc. (NASDAQ: LPCN), a...

Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024

Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024 PR Newswire SALT LAKE CITY, May 8, 2024 SALT LAKE CITY, May 8, 2024...

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 PR Newswire SALT LAKE CITY, May 1, 2024 Pivotal study design aligned with FDA on streamlined...

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity PR Newswire SALT LAKE CITY, April 11, 2024 LPCN 2401 treatment resulted in...

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis PR Newswire SALT LAKE CITY, March 28, 2024 Met primary and Hepaticย Encephalopathy (HE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1006.596.986.35233476.65564201CS
41.9441.72043010754.656.984.61297315.6167455CS
122.9279.56403269753.677.153.2724515.79999264CS
264.16171.1934156382.437.152.38471135.18166034CS
521.9140.8119658124.687.152.3101698114.95313431CS
156-13.81-67.696078431420.432.132.310134112517.8324439CS
260-20.27-75.465376023826.8659.52.310198694823.40024783CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.9393
(129.10%)
576.2M
BNAIBrand Engagement Network Inc
$ 2.6062
(105.21%)
108.22M
ONCOOnconetix Inc
$ 0.2949
(79.93%)
137.82M
ASTSAST SpaceMobile Inc
$ 9.0199
(69.23%)
109.9M
KTRAKintara Therapeutics Inc
$ 0.272
(44.76%)
81.59M
FFIEFaraday Future Intelligent Electric Inc
$ 0.4379
(-62.57%)
417.92M
AWINAERWINS Technologies Inc
$ 5.555
(-39.22%)
2.01M
HLTHCue Health Inc
$ 0.0553
(-38.96%)
72.11M
GWAVGreenwave Technology Solutions Inc
$ 0.0494
(-37.15%)
676.15M
PLTNUPlutoniam Acquisition Corporation
$ 5.83
(-34.57%)
965
GWAVGreenwave Technology Solutions Inc
$ 0.0494
(-37.15%)
676.15M
LUCYInnovative Eyewear Inc
$ 0.9393
(129.10%)
576.2M
FFIEFaraday Future Intelligent Electric Inc
$ 0.4379
(-62.57%)
417.92M
RSLSReShape Lifesciences Inc
$ 0.2847
(37.01%)
212.55M
AALAmerican Airlines Group Inc
$ 11.62
(-13.54%)
159.16M

LPCN Discussion

View Posts
Monksdream Monksdream 1 month ago
LPCN under $10
๐Ÿ‘๏ธ0
Awl416 Awl416 2 months ago
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
LPCN under $10
๐Ÿ‘๏ธ0
Monksdream Monksdream 4 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
๐Ÿ‘๏ธ0
Monksdream Monksdream 10 months ago
Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 1 year ago
Bottom was in on the eighth
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 1 year ago
Added
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
Clueless
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Forward split then, lol. Shelf offering! Dilution!
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
Yes but that is the exact opposite of a reverse split which is what you said. Reverse splits lower share countโ€ฆ.
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Increasing authorized shares can have the same end result as a split, meaning each share can be worth less, due to more shares.
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
Increasing authorized shares is not a reverse split โ€ฆ.
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
There is no reverse split vote!
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Yes, I'm voting to reverse split.
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 2 years ago
There is no reverse split vote โ€ฆ.
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Dilution, reverse split, recession and bankruptcy.

DRSRB!
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Well, with the upcoming reverse split vote, if approved, leads to dilution, thereby pushing the stock price down.
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 2 years ago
I am amazed that LPCN is now 0.92. Testosterone replacement therapy is a large market. Will sales disappoint for a reason?
๐Ÿ‘๏ธ0
Pyramid2 Pyramid2 2 years ago
"I" am always amazed when a small cap BIO gets approval for their testosterone pill over a Big Pharma that stole it and gets nailed to cross makes their stock sink?, "I" guess girls with Testosterone and Males with LPCN so no MALES in this market/world? On Watch for some males...
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
This LPCN message board ROCKS!!!
๐Ÿ‘๏ธ0
RunninRobert RunninRobert 2 years ago


In my last summary (Jan2022) the stock was under a dollar and now its looking strong, I am very bullish going forward with it. Not alot of downside ATM
๐Ÿ‘๏ธ0
MF2 MF2 2 years ago
28 of march TLANDO pdufa, 10th march financials, this stock may grow until the approval date and over.
๐Ÿ‘๏ธ0
MF2 MF2 2 years ago
28 march pdufa for TLANDO and 10th sec filling am I wrong? I think this stock is going to grow constantly until 28th of march and over.
๐Ÿ‘๏ธ0
gi197845 gi197845 2 years ago
Something, nothing, anything, everything!
๐Ÿ‘๏ธ0
everyonesguess everyonesguess 2 years ago
You said ever thing and nothing. Perfect job done.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Yes, you are correct, in March 2022, Tlando can be marketed to the public.
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 3 years ago
I remember that March 2022 is when the exclusivity for Clarus was going to end and that we could then sell our oral testosterone pills called Tlando. That was a provisional FDA decision. Is this still the case?
Thanks
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Shart!!!
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 3 years ago
If the news was good with the NASH data why is the stock flat to down?
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Well the NASH news is out and the results are good.
๐Ÿ‘๏ธ0
LQMTinvestor2018 LQMTinvestor2018 3 years ago
Any time this month
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 3 years ago
When are we expecting NASH data? Thanks.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Someday this stock price will either go up or go down. I'm so glad I could help.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
It's going to be a win win.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Do'h!
๐Ÿ‘๏ธ0
Vance Vance 3 years ago
Actually things look pretty darn good! Lawsuit aside, our pipeline is intact & progressing. TLando will still gain full approval next March, partnership news imminent (possibly soon after A/S increase),
1144 results due in a couple months with no bad expectations... yeah I'd say things are looking pretty good!
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Yes, things don't look good for Lipocine or its' investors.
๐Ÿ‘๏ธ0
Rapier1911 Rapier1911 3 years ago
https://ih.advfn.com/stock-market/NASDAQ/lipocine-LPCN/stock-news/85206412/clarus-therapeutics-defeats-lipocines-patent-infri
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Quite the range today, 1.25 to 1.56.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Correction, huge volume today.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Wow, big volume today.
๐Ÿ‘๏ธ0
Vance Vance 3 years ago
Not yet
๐Ÿ‘๏ธ0
BesaoT35 BesaoT35 3 years ago
Is there a date for the Clarus court case?
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Do'h @ 1.38 now...
How low can she go?
She be going down~!
๐Ÿ‘๏ธ0
Vance Vance 3 years ago
Are you still long on LPCN?
I Am Long.

How long have you been in LPCN?
I Came Across Lipocine in August of last year.

Do you care to share your average pps or number of shares?
I have bought and sold my holdings several times to place other trades, ultimately resulting in an increase in current shares held.

It appears that Lipocine has not interest in suing in court. What's the court status?
Court status is apparent, awaiting trial scheduling. Lipocine brought the suit against Clarus to sue in court.

I don't think Lipocine is going to get a favorable deal for marketing Tlando. Am I being too negative? When will we hear about a partnership?
It is my opinion the litigation against Clarus and/or Phase 2 1144 results would need to wrap up before a partnering announcement. However, talks are obviously ongoing per an overly excited birdy named Patel. TLando is a money maker, any partner will know that!



It is anybodys guess as to when a good catalyst will hit; analyst upgrade, pipeline news, partnership, trial, nash results, etc.. so my mention of selling to run trades is risky. But, I've been lucky with timing and I Only jump ship on damn good prospects of a daytrade or overnight hold. Long and short alike. You might try paper trading your position (no risk) to see how you do with that, then jump in sometime if you feel confident. No risk, no reward!

As for Long term vs under 12 month holds, taxes are not my concern. Profit is, and if I turn a buck into two and have to pay forty cents, I'm still sixty cents up!

G'luk

๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
I wonder what the results of the court case are and when it will reported? Meanwhile the share price is going down, down, down, to the burning ring of fire...
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
It's a pretty substantial drop from 1.47 to 1.37 today. We'll see what the future holds for this.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Thanks Vance, thus far I think it's been proven that an r/s is not up for a vote, it's the dilution that's up for a vote.

Are you still long on LPCN?
How long have you been in LPCN?
Do you care to share your average pps or number of shares?

I'm not trying to be negative here, but here are some of my thoughts...

It's a shame that Tlando only got tentative approval, for marketing in March 2022, due to the fraudulent exclusivity of Jatenzo.

It appears that Lipocine has not interest in suing in court. What's the court status?

It appears that no one would want a 2 or 3 times per day Tlando pill, when Xtlando, with a once per day dose would be preferred.

It appears that no one, the FDA, patients, or big pharma has much if any interest in a T-booster pill.

I don't think Lipocine is going to get a favorable deal for marketing Tlando. Am I being too negative? When will we hear about a partnership?

Positive Nash results will be a bigger deal than Tlando, or at least a good catalyst. Unfortunately, I guess it wasn't tested on alcoholics livers, but if it treats fatty livers good, maybe it could be prescribed off label to alcoholics...

As of writing this, I'm not under water. I'm considering to bale out in full now and if I do that, I'm considering getting back in, in early 2023.

Also, the Biden Admin wants price controls/socialized medicine, which might even happen with another executive order, so lower profits for big pharma, hedge funds and us retail investors. As well as lower research capital for new drugs...

Drug costs can't just be fixed with price controls, they also need to lower NDA and SNDA costs with the FDA as well as somehow reduce the cost of drug trials.

I was under water for a,ong time on, LPCN after the FDA first reject Tlando, so I bought more and up above water now, but I mostly just see cash burning and delays here.

In the extremely long run LPCN could be a win, but if I stay in I think I'll go undwer water as the stock price tanks for the next year or so...

Am I'm being too negative and paranoid or am I being realistic. What are your thoughts?

Thank you.
๐Ÿ‘๏ธ0
Vance Vance 3 years ago
You really ought to sell any shares you have in Lipocine if you believe there is any truth to your assessment.
๐Ÿ‘๏ธ0
gi197845 gi197845 3 years ago
Before or after the r/s and dilution?
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock